Center-Authored Papers

Filters: Author is Lee, Stephanie  [Clear All Filters]
2008
Lee SJ, Flowers MED.  2008.  Recognizing and managing chronic graft-versus-host disease.. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. :134-41. Abstract
Griffith LM, Pavletic SZ, Lee SJ, Martin PJ, Schultz KR, Vogelsang GB.  2008.  Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(4):379-84.
Flowers MED, Storer BE, Carpenter PA, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem H-P, Fero ML, Georges GE et al..  2008.  Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(12):1380-4. Abstract
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.  2008.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(2):197-207. Abstract
Treister NS, Cook EF, Antin J, Lee SJ, Soiffer R, Woo S-B.  2008.  Clinical evaluation of oral chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(1):110-5. Abstract
Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R et al..  2008.  Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(7):748-58. Abstract
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
Lee SJ, Richardson PG, Sonneveld P, Schuster MW, Irwin D, San Miguel J-F, Crawford B, Massaro J, Dhawan R, Gupta S et al..  2008.  Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.. British journal of haematology. 143(4):511-9. Abstract
Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR, Bevans M et al..  2008.  Variation in supportive care practices in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1231-8. Abstract
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
2009
Lee SJ, Seaborn T, Mao FJ, Massey SC, Luu NQ, Schubert MA, Chien JW, Carpenter PA, Moravec C, Martin PJ et al..  2009.  Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(4):416-20. Abstract
Loberiza FR, Lee SJ, Freytes CO, Giralt SA, van Besien K, Kurian S, del Cerro P, Toro JJ, Williams LA, Ketelsen SW et al..  2009.  Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(8):903-9. Abstract
McCarroll SA, Bradner JE, Turpeinen H, Volin L, Martin PJ, Chilewski SD, Antin JH, Lee SJ, Ruutu T, Storer BE et al..  2009.  Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.. Nature genetics. 41(12):1341-4. Abstract
Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C et al..  2009.  Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(12):1543-54. Abstract
Majhail NS, Flowers MED, Ness KK, Jagasia M, Carpenter PA, Arora M, Arai S, Johnston L, Martin PJ, Baker KS et al..  2009.  High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.. Bone marrow transplantation. 43(1):49-54. Abstract
Goldman RE, Sullivan A, Back AL, Alexander SC, Matsuyama RK, Lee SJ.  2009.  Patients' reflections on communication in the second-opinion hematology-oncology consultation.. Patient education and counseling. 76(1):44-50. Abstract
Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem H-P, Fero ML, Warren EH, Lee SJ, Appelbaum FR et al..  2009.  Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.. Blood. 114(3):702-8. Abstract
Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S.  2009.  Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians.. Pediatrics. 123(3):1011-7. Abstract
Mielcarek M, Storer BE, Boeckh MJ, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers MED, Doney K, Lee SJ et al..  2009.  Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.. Blood. 113(13):2888-94. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn J-Y, Cervantes F, Copelan E et al..  2009.  Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(11):1475-8. Abstract
2010
Nguyen Y, Al-Lehibi A, Gorbe E, Li E, Haagenson M, Wang T, Spellman S, Lee SJ, Davidson NO.  2010.  Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.. Blood. 115(17):3625-31. Abstract
van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UAI, Douglas KW, Jones DA, Lee SJ, Pulsipher M, Ritchie L, Halter J, Shaw BE.  2010.  Family donor care management: principles and recommendations.. Bone marrow transplantation. 45(8):1269-73. Abstract
Tedeschi SK, Savani BN, Jagasia M, Engelhardt B, Anasetti C, Barrett JA, Lee S.  2010.  Time to consider HPV vaccination after allogeneic stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(8):1033-6. Abstract
Lee SJ.  2010.  Have we made progress in the management of chronic graft-vs-host disease? Best practice & research. Clinical haematology. 23(4):529-35. Abstract